Research

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658May 3, 2012

NSAIDs and Cardiovascular Risk Explained, According to Studies From Penn's Perelman School of Medicine

After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.

facebook twitter google print email
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659May 2, 2012

Genetically Modified T Cell Therapy Shown to Be Safe, Lasting in Penn Medicine Study of HIV Patients

HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine. The results provide a framework for the use of this type of gene therapy as a powerful weapon in the treatment of HIV, cancer, and a wide variety of other diseases.

facebook twitter google print email
Media Contact:Jill DiSanto | jdisanto@upenn.edu | 215-898-4820May 3, 2012

Penn’s Center for High Impact Philanthropy Launches Development of Child-Survival Tool Kit for Donors

Each year, before reaching age age 5, almost 8 million children die from preventable causes. The University of Pennsylvania’s Center for High Impact Philanthropy at the School of Social Policy & Practice is doing something about it.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194May 1, 2012

Three Penn Faculty Elected to the National Academy of Sciences

PHILADELPHIA — Nancy Bonini, Gideon Dreyfuss and Beatrice H. Hahn of the University of Pennsylvania have been elected members of the National Academy of Sciences, considered one of the highest honors that can be accorded a U.S. scientist or engineer.

facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604April 30, 2012

Penn Scientists Develop Large-scale Simulation of Human Blood

PHILADELPHIA — Having a virtual copy of a patient’s blood in a computer would be a boon to researchers and doctors. They could examine a simulated heart attack caused by blood clotting in a diseased coronary artery and see if a drug like aspirin would be effective in reducing the size of such a clot.

facebook twitter google print email
Media Contact:Katie Delach | Katie.Delach@uphs.upenn.edu | 215-349-5964April 30, 2012

Penn Study Confirms 2 Treatments for Age-related Macular Degeneration Provide Equal Vision Improvements

Two drugs commonly used to treat age-related macular degeneration (AMD) yield similar improvements in vision for patients receiving treatments on a monthly or as-needed basis, according to a study from researchers at the Center for Preventive Ophthalmology and Biostatistics (CPOB) at the Perelman School of Medicine at the University of Pennsylvania.

Accidental Shortness

April 30, 2012

Sarah Tishkoff of the School of Arts and Sciences and the Perelman School of Medicine is featured for her genetic analysis of Pygmies.

Article Source: Philly.com

For Pygmies, Size May Not Matter

April 26, 2012

Sarah Tishkoff of the School of Arts and Sciences and Perelman School of Medicine discuss her research on Pygmies’ DNA.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194April 26, 2012

Penn Geneticists Identify Genes Linked to Western African Pygmies’ Small Stature

PHILADELPHIA — If Pygmies are known for one trait, it is their short stature: Pygmy men stand just 4’11” on average.  But the reason why these groups are so short and neighboring groups are not remains unclear.  Scientists have proposed various theories based on natural selection, including that Pygmies’ reduced size lowered nutritional requirements, helped them better handle hot climates, or allowed them to reach sexual maturity at an earlier age.

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658April 24, 2012

Penn Research: Gatekeeper of Brain Steroid Signals Boosts Emotional Resilience to Stress

A cellular protein called HDAC6, newly characterized as a gatekeeper of steroid biology in the brain, may provide a novel target for treating and preventing stress-linked disorders, such as depression and post-traumatic stress disorder (PTSD), according to research from the Perelman School of Medicine at the University of Pennsylvania.